David Banta

1.7k total citations
49 papers, 1.1k citations indexed

About

David Banta is a scholar working on Economics and Econometrics, General Health Professions and Medical Laboratory Technology. According to data from OpenAlex, David Banta has authored 49 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Economics and Econometrics, 11 papers in General Health Professions and 9 papers in Medical Laboratory Technology. Recurrent topics in David Banta's work include Health Systems, Economic Evaluations, Quality of Life (29 papers), Pharmaceutical Economics and Policy (16 papers) and Quality and Safety in Healthcare (9 papers). David Banta is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (29 papers), Pharmaceutical Economics and Policy (16 papers) and Quality and Safety in Healthcare (9 papers). David Banta collaborates with scholars based in Netherlands, United States and Canada. David Banta's co-authors include Wija Oortwijn, Egon Jonsson, E Jonsson, Liz Maria de Almeida, Lars Werkö, Stephen B. Thacker, Alı́cia Granados, Andrew Stevens, Hindrik Vondeling and Chris Henshall and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and American Journal of Public Health.

In The Last Decade

David Banta

47 papers receiving 974 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Banta Netherlands 18 800 387 129 118 94 49 1.1k
Chris Henshall United Kingdom 17 597 0.7× 341 0.9× 146 1.1× 52 0.4× 27 0.3× 32 945
Corinna Sorenson United Kingdom 16 574 0.7× 313 0.8× 75 0.6× 33 0.3× 31 0.3× 41 877
Donna Rindress Canada 11 694 0.9× 376 1.0× 69 0.5× 41 0.3× 33 0.4× 20 933
Pamela Mazzocato Sweden 17 330 0.4× 518 1.3× 161 1.2× 47 0.4× 103 1.1× 37 1.4k
Étienne Minvielle France 20 250 0.3× 536 1.4× 221 1.7× 96 0.8× 17 0.2× 116 1.3k
Mark McClellan United States 6 581 0.7× 526 1.4× 50 0.4× 31 0.3× 8 0.1× 9 839
Markus Kraus Austria 17 470 0.6× 542 1.4× 93 0.7× 116 1.0× 6 0.1× 54 1.1k
Regina E. Herzlinger United States 13 501 0.6× 455 1.2× 128 1.0× 86 0.7× 4 0.0× 55 1.2k
Erwin A. Blackstone United States 11 379 0.5× 271 0.7× 148 1.1× 88 0.7× 5 0.1× 42 971
Joseph P. Fuhr United States 11 368 0.5× 257 0.7× 154 1.2× 44 0.4× 5 0.1× 45 973

Countries citing papers authored by David Banta

Since Specialization
Citations

This map shows the geographic impact of David Banta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Banta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Banta more than expected).

Fields of papers citing papers by David Banta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Banta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Banta. The network helps show where David Banta may publish in the future.

Co-authorship network of co-authors of David Banta

This figure shows the co-authorship network connecting the top 25 collaborators of David Banta. A scholar is included among the top collaborators of David Banta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Banta. David Banta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Picon, Paulo Dornelles, et al.. (2013). NATIONAL GUIDELINES FOR HIGH-COST DRUGS IN BRAZIL: ACHIEVEMENTS AND CONSTRAINTS OF AN INNOVATIVE NATIONAL EVIDENCE-BASED PUBLIC HEALTH POLICY. International Journal of Technology Assessment in Health Care. 29(2). 198–206. 6 indexed citations
2.
Oortwijn, Wija, et al.. (2010). The role of health technology assessment on pharmaceutical reimbursement in selected middle-income countries. Health Policy. 95(2-3). 174–184. 68 indexed citations
3.
Banta, David & Liz Maria de Almeida. (2009). The development of health technology assessment in Brazil. International Journal of Technology Assessment in Health Care. 25(S1). 255–259. 34 indexed citations
4.
Banta, David. (2009). Health Technology Assessment in Latin America and the Caribbean. International Journal of Technology Assessment in Health Care. 25(S1). 253–254. 22 indexed citations
5.
Banta, David, et al.. (2009). Development of health technology assessment in France. International Journal of Technology Assessment in Health Care. 25(S1). 108–111. 19 indexed citations
6.
Banta, David, Finn Børlum Kristensen, & Egon Jonsson. (2009). A history of health technology assessment at the European level. International Journal of Technology Assessment in Health Care. 25(S1). 68–73. 39 indexed citations
7.
Banta, David & Wija Oortwijn. (2009). The Netherlands. International Journal of Technology Assessment in Health Care. 25(S1). 143–147. 5 indexed citations
8.
Chen, Yingyao, et al.. (2009). Health technology assessment development in China. International Journal of Technology Assessment in Health Care. 25(S1). 202–209. 28 indexed citations
9.
Drummond, Michael & David Banta. (2009). Health technology assessment in the United Kingdom. International Journal of Technology Assessment in Health Care. 25(S1). 178–181. 14 indexed citations
10.
Banta, David, Egon Jonsson, & Paul Childs. (2009). History of the international societies in health technology assessment: International Society for Technology Assessment in Health Care and Health Technology Assessment International. International Journal of Technology Assessment in Health Care. 25(S1). 19–23. 13 indexed citations
11.
Banta, David & Egon Jonsson. (2009). History of HTA: Introduction. International Journal of Technology Assessment in Health Care. 25(S1). 1–6. 71 indexed citations
12.
Banta, David. (2003). The development of health technology assessment. Health Policy. 63(2). 121–132. 206 indexed citations
13.
Banta, David. (2002). Economic Development Key to Healthier World. JAMA. 287(24). 3195–3195. 6 indexed citations
14.
Banta, David & Wija Oortwijn. (2001). Health Technology Assessment and Health Care in the European Union. SHILAP Revista de lepidopterología. 10(1). 29–37. 8 indexed citations
15.
Henshall, Chris, Wija Oortwijn, Andrew Stevens, Alı́cia Granados, & David Banta. (1997). Priority Setting for Health Technology Assessment: Theoretical Considerations and Practical Approaches: A paper produced by the Priority Setting Subgroup of the EUR-ASSESS Project. International Journal of Technology Assessment in Health Care. 13(2). 144–185. 68 indexed citations
16.
Banta, David, et al.. (1997). EUR-ASSESS Project Subgroup Report on Coverage. International Journal of Technology Assessment in Health Care. 13(2). 287–332. 23 indexed citations
17.
Vondeling, Hindrik, Henk Rosendal, & David Banta. (1995). Evaluation and diffusion of excimer laser treatment of myopia in the United States and in the Netherlands. Health Policy. 34(1). 21–33. 2 indexed citations
18.
Banta, David. (1992). DEVELOPING OUTCOME STANDARDS FOR QUALITY ASSURANCE ACTIVITIES. International Journal for Quality in Health Care. 4(1). 25–32. 7 indexed citations
19.
Banta, David. (1987). Technology assessment and quality assurance.. PubMed. 7(24). 48–51. 6 indexed citations
20.
Banta, David, et al.. (1979). Is medical technology safe?. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 53(11). 110–2. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chris Henshall Breakdown of academic impact, for papers by Corinna Sorenson Breakdown of academic impact, for papers by Donna Rindress Breakdown of academic impact, for papers by Pamela Mazzocato Breakdown of academic impact, for papers by Étienne Minvielle Breakdown of academic impact, for papers by Mark McClellan Breakdown of academic impact, for papers by Markus Kraus Breakdown of academic impact, for papers by Regina E. Herzlinger Breakdown of academic impact, for papers by Erwin A. Blackstone Breakdown of academic impact, for papers by Joseph P. Fuhr
Rankless by CCL
2026